Streetbeat News

Products Services

ATVI

MSFT

Microsoft Corporation (NASDAQ:MSFT) has reported a 13% quarter-on-quarter revenue growth, largely attributed to the success of Xbox Game Pass, which saw a significant increase in subscribers following the launch of 'Starfield'. Despite a 7% decline in hardware sales, Xbox is experiencing a substantial upswing. Microsoft's acquisition of Activision Blizzard Inc (NASDAQ:ATVI) is expected to further enhance the Game Pass offerings.

Portfolio Pulse from Franca Quarneti

October 25, 2023 | 4:46 pm

ACN

STGW

Accenture (NYSE:ACN) has agreed to acquire healthcare marketing agency ConcentricLife, a subsidiary of Stagwell (NASDAQ:STGW). The acquisition is aimed at enhancing Accenture's healthcare marketing and communications capabilities for the life sciences industry. ConcentricLife's 270+ employees will join Accenture Song in various markets. The global healthcare market is expected to grow to $665 billion by 2028.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 4:40 pm

BIVI

BioVie Inc. (NASDAQ:BIVI) has presented blinded data from its Phase 3 clinical trial of NE3107 for the treatment of mild to moderate Alzheimer's Disease. The data suggests that NE3107 is biologically active and may have an impact on cognitive, biomarker, and imaging endpoints. Statistically significant population changes from baseline were observed for all primary and secondary cognitive and functional assessments measured. The company expects to announce unblinded, topline data from this trial in late November or early December.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 4:33 pm

BIIB

Biogen Inc. has reported new Phase 1b clinical data from the study of BIIB080, a therapy targeting tau in mild Alzheimer's disease. The data showed favorable trends on multiple exploratory endpoints of cognition and activities of daily living. The results were presented at the 2023 Clinical Trials on Alzheimer's Disease meeting. Biogen is currently recruiting for the Phase 2 CELIA study, evaluating the potential for this therapy to slow the worsening of mild cognitive impairment or mild dementia due to Alzheimer's disease. BIIB shares are trading lower by 2.26% to $246.41.

Portfolio Pulse from Nabaparna Bhattacharya

October 25, 2023 | 4:20 pm

MSFT

NVDA

Microsoft Corp (MSFT) is in the early stages of its major AI opportunity, with its cloud service Azure growing by 29% due to demand for AI tech stack. The company's acquisition of Activision is expected to strengthen its position in video gaming. Microsoft and Nvidia are currently the best two stocks for artificial intelligence among the 'magnificent seven' stocks, which also include Apple, Amazon, Alphabet, Meta Platforms, and Tesla.

Portfolio Pulse from The Arora Report

October 25, 2023 | 4:12 pm

AMZN

Amazon.com, Inc (NASDAQ:AMZN) is set to report its Q3 financial results on October 26, 2023. Analysts expect the company to report a revenue of $141.44 billion and earnings per share of 58 cents. The company's previous guidance calls for Q3 revenue to be in the range of $138 billion to $143 billion. Analysts are mostly bullish on Amazon, expecting retail growth, margin improvement, and strong AWS growth. Key items to watch include the company's AWS platform, the 2023 holiday season, the growth of Prime Video subscription, and the company's future AI plans.

Portfolio Pulse from Chris Katje

October 25, 2023 | 4:02 pm

NFLX

Netflix (NASDAQ:NFLX) reported strong Q3 2023 earnings, driven by its content slate and the introduction of advertising in 12 countries. The company saw a 70% increase in ad plan membership quarter-to-quarter. Netflix expects a more balanced mix of membership and Average Revenue per Member (ARM) growth in the future. However, potential challenges include the ongoing SAG-AFTRA strike impacting content production and spending, and the balance between margin improvement and growth investments.

Portfolio Pulse from Tornado

October 25, 2023 | 3:55 pm

BA

SPR

Boeing's CFO anticipates a modest increase in R&D expenditure over the next few years, but does not expect it to impact the company's cash flow goal. The CEO views the Spirit remedy as unique and believes that rates can solve most supply chain issues.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 3:28 pm

MATICUSD

Polygon Labs plans to replace its MATIC token with a new POL token on the Ethereum mainnet. The new token is part of the upcoming Polygon 2.0 upgrade and will serve as the main cryptocurrency for the Polygon 2.0 ecosystem. The replacement will not be immediate and requires governance approval. MATIC holders will have four years to migrate their holdings to the new token. The trading volume of MATIC has dropped by 33.9% in the past 24 hours, and its price is down around 1%.

Portfolio Pulse from Khyathi Dalal

October 25, 2023 | 3:21 pm

ALNY

Alnylam Pharmaceuticals (NASDAQ:ALNY) has reported positive interim results for the Phase 1 study of ALN-APP, a treatment for Alzheimer's disease and cerebral amyloid angiopathy (CAA). The study showed sustained pharmacodynamic activity up to 10 months after administration and marked reductions in Aβ42 and Aβ40, amyloid fragments implicated in Alzheimer's disease and CAA. The first patient has been dosed in the multiple-dose Part B portion of the study, which is proceeding in Canada, UK, and the Netherlands. The study remains on partial clinical hold in the U.S. due to findings observed in non-clinical chronic toxicology studies.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 3:05 pm